claim
A 2016 systematic review of clinical trials published in the previous 25 years found that ayahuasca, psilocybin, and lysergic acid diethylamide (LSD) demonstrate antidepressive, anxiolytic, and antiaddictive effects.

Authors

Sources

Referenced by nodes (4)